InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

FATE THERAPEUTICS INC

FATE Clue Score25
United States Fiscal year ends December CIK 0001434316 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Yuan Xu
6 Aug 2024
Director
Sold on a plan
633
$4.23
$2.68K
Edward J Dulac III
4 Mar 2024
Chief Financial Officer
Sold on a plan
2,447
$7.77
$19.01K
Edward J Dulac III
29 Jan 2024
Chief Financial Officer
Sold on a plan
1,849
$5.00
$9.25K
Edward J Dulac III
2 Jan 2024
Chief Financial Officer
Sold on a plan
5,182
$3.66
$18.97K
Edward J Dulac III
18 Dec 2023
Chief Financial Officer
Sold on a plan
1,585
$3.50
$5.55K
Cindy Tahl
9 Nov 2023
General Counsel and Secretary
Sold on a plan
24,363
$2.40
$58.47K
Yuan Xu
4 Aug 2023
Director
Sold on a plan
632
$3.71
$2.34K
Edward J Dulac III
5 Jul 2023
Chief Financial Officer
Sold on a plan
5,182
$4.83
$25.03K
Yuan Xu
14 Jun 2023
Director
Sold on a plan
3,460
$5.58
$19.31K
Yu-Waye Chu
18 Apr 2023
Chief Medical Officer
Sold on a plan
2,317
$6.58
$15.25K
Yu-Waye Chu
18 Apr 2023
Chief Medical Officer
Sold on a plan
215
$6.52
$1.40K
Showing 250 of 388 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 299
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 21
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 155
Sales at will 198
Transactions with no price 0
Shares from compensation/vesting 38,862,198
Sales filed before the plan box existed 178
History held since 7 Oct 2013